Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for AQB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 11.71M
March 31, 2026 10.25M
December 31, 2025 10.34M
September 30, 2025 24.17M
June 30, 2025 26.65M
March 31, 2025 29.43M
September 30, 2024 117.79M
June 30, 2024 127.44M
March 31, 2024 176.18M
December 31, 2023 187.55M
September 30, 2023 192.55M
June 30, 2023 210.22M
March 31, 2023 206.29M
December 31, 2022 213.84M
September 30, 2022 222.69M
June 30, 2022 220.14M
March 31, 2022 221.65M
December 31, 2021 228.44M
September 30, 2021 231.35M
June 30, 2021 238.27M
March 31, 2021 242.54M
December 31, 2020 125.78M
September 30, 2020 69.60M
June 30, 2020 38.50M
March 31, 2020 41.41M
Date Value
December 31, 2019 30.23M
September 30, 2019 32.96M
June 30, 2019 36.77M
March 31, 2019 33.03M
December 31, 2018 27.67M
September 30, 2018 26.04M
June 30, 2018 28.26M
March 31, 2018 31.49M
December 31, 2017 23.73M
September 30, 2017 25.30M
June 30, 2017 26.91M
March 31, 2017 28.55M
December 31, 2016 5.709M
September 30, 2016 5.193M
June 30, 2016 4.105M
March 31, 2016
December 31, 2015 2.637M
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014 6.608M
September 30, 2014 8.424M
June 30, 2014 10.27M
March 31, 2014 11.82M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Agenus, Inc. 172.69M
Alnylam Pharmaceuticals, Inc. 5.559B
Amgen, Inc. 95.64B
Anika Therapeutics, Inc. 183.47M

Total Assets (Quarterly) Related Metrics